Search

Your search keyword '"Rivaroxaban -- Dosage and administration -- Testing"' showing total 4 results
Start Over Descriptor "Rivaroxaban -- Dosage and administration -- Testing" Publication Year Range Last 50 years
4 results on '"Rivaroxaban -- Dosage and administration -- Testing"'

1. Studies from Chinese Academy of Medical Sciences in the Area of Purpura Published (Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a ...)

Subjects
Testing, Diagnosis, Drug therapy, Risk factors, Dosage and administration, Health aspects, Vasculitis -- Diagnosis -- Risk factors -- Drug therapy, Blood coagulation factors -- Health aspects, Rivaroxaban -- Dosage and administration -- Testing
Abstract

2024 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on purpura. According to news reporting out of [...]

Published
2024

2. Data from Paracelsus Medical University Provide New Insights into COVID-19 (Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during ...)

Subjects
Testing, Prevention, Complications and side effects, Risk factors, Dosage and administration, Sudden cardiac death -- Risk factors -- Prevention, Atrial fibrillation -- Risk factors -- Prevention, Rivaroxaban -- Dosage and administration -- Testing, COVID-19 -- Complications and side effects, Cardiac arrest -- Risk factors -- Prevention
Abstract

2023 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on COVID-19. According to news reporting out of [...]

Published
2023

3. Researcher at First Affiliated Hospital of Wenzhou Medical University Discusses Research in Thromboembolism (Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk ...)

Subjects
Testing, Prevention, Risk factors, Dosage and administration, Postoperative complications -- Prevention, Rivaroxaban -- Dosage and administration -- Testing, Hemorrhage -- Risk factors -- Prevention, Surgery -- Complications
Abstract

2023 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on thromboembolism have been published. According to news reporting [...]

Published
2023

4. Feinstein Institute for Medical Research Researcher Provides Details of New Studies and Findings in the Area of Factor Xa Inhibitors (Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the ...)

Subjects
Testing, Care and treatment, Patient outcomes, Dosage and administration, Aspirin -- Dosage and administration -- Testing, Thromboembolism -- Patient outcomes -- Care and treatment, Rivaroxaban -- Dosage and administration -- Testing
Abstract

2022 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on factor Xa inhibitors is the subject of a new [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results